Patients with the hyperimmunoglobulin E and recurrent infection syndrome (HIE) characteristically have frequent skin and respiratory infections caused by Staphylococcus aureus. We have developed a set of enzyme-linked immunosorbent assays that use whole S. aureus (Wood's strain) immobilized on 0.22-um filters and highly specific, affinity-purified enzyme conjugates of goat anti-human IgE, anti-human IgD, anti-human IgG, anti-human IgA, and anti-human IgM. These reagents were used to determine S. aureus-specific immunoglobulin (Ig) levels. As previously published, 10 patients with HIE had markedly higher levels of anti-S. aureus IgE than did 5 patients with eczema and recurrent superficial S. aureus infections (P < 0.001). The HIE patients were also found to have a deficit of anti-S. aureus serum IgA as compared with 12 normal subjects, 12 patients with chronic granulomatous disease, 5 patients with chronic eczema and recurrent superficial S. aureus infections, and 3 patients with the Chediak-Higashi syndrome (P < 0.01 for each comparison). In addition, the HIE patients had an excess of anti-S. aureus IgM as compared with normal subjects (P < 0.01). An expected excess of anti-S. aureus IgG was absent. These abnormalities cannot be explained by variations of total serum Ig levels or by a general inability to produce antigen-specific IgA because levels of naturally occurring IgA antibody against Escherichia coli lipopolysaccharide and the antigens of the pneumococcal vaccine are normal. Parotid saliva from patients with HIE contained less salivary IgA per milligram of protein (P < 0.01) and less salivary anti-S. aureus IgA per milligram of protein (P < 0.05) than did normal controls. The incidence of infection at mucosal surfaces and adjacent lymph nodes correlated inversely with serum anti-S. aureus IgA (r = -0.647, P = 0.034), serum anti-S. aureus IgE (r = -0.731, P = 0.016), total serum IgE (r = -0.714, P = 0.020), and total serum IgD (r = -0.597, P = 0.049). These findings are evidence of a previously undescribed immunoregulatory defect in patients with HIE, which may contribute to the increased susceptibility to infection in this syndrome.
Introduction
The hyperimmunoglobulin E and recurrent infection (Job's) syndrome (HIE)' is a complex disorder characterized by onset early in life, markedly elevated serum IgE, and sdrious recurrent bacterial infections of the skin and sinopulmonary tract (1, 2) . These skin infections are frequently "cold" subcutaneous abscesses caused by Staphylococcus aureus, the most common bacterial pathogen in this syndrome. The middle and external ear, mastoid processes, gingiva, bronchi, and lungs are the other frequent sites of bacterial infection. Additional characteristics of the syndrome include coarse facies, chronic eczematoid dermatitis, mild eosinophilia, and mucocutaneous candidiasis.
In addition to the hallmark of increased serum IgE, reported immunologic abnormalities include the presence of anti-S. aureus and anti-Candida albicans IgE (3) (4) (5) , elevated total IgD (6) , and a neutrophil chemotactic defect (7) (8) (9) possibly caused by suppressive factors released from mononuclear cells (10, 11) . In addition, there are deficiencies of delayed hypersensitivity (2, 12) , in vitro proliferative responses to C. albicans (1, 4, 12) , proliferative responses in mixed lymphocyte cultures (1) , anamnestic antibody responses to tetanus and diphtheria antigens (1) , in vitro response to pokeweed mitogen (13) and concanavalin A (12) , and suppressor T cell number and function (14) . The presence of anti-S. aureus IgE (3) (4) (5) led to the hypothesis that other abnormalities of the humoral immune response to S. aureus could be present and contribute to the marked predisposition to S. aureus infection in this syndrome (4) . Therefore, we have measured the anti-S. aureus Ig levels in the serum and saliva from HIE patients and from control groups by use of a new, highly sensitive and specific enzymelinked immunosorbent assay (ELISA) for anti-S. aureus IgG, IgA, IgM, IgE, and IgD. HIE patients have deficiencies of serum anti-S. aureus IgA, salivary IgA, and salivary anti-S. aureus IgA. In addition, there is an inverse correlation between the levels of serum anti-S. aureus IgA, serum anti-S. aureus IgE, total serum IgE, total serum IgD, and the number of infections at mucosal surfaces and in adjacent lymph nodes.
Methods Subjects
Normal subjects. 39 healthy people (aged 20-39; mean±SEM 30.9±0.9) were studied. Serum samples from nine of them were obtained on a single morning, pooled in equal volumes, and divided into l-ml aliquots. A freshly thawed sample of this reference pool was used to standardize each assay of anti-S. aureus IgG, IgA, and IgM. These subjects were not used to determine the normal range.
Patients with HIE. Total Ig levels were determined for 11 patients (aged 10-45; mean±SEM = 22.6±3.1) who were followed at the National Institutes of Health (NIH) and who manifested "classic" HIE (patients No. [1] [2] [3] [4] [5] 17 , and 9-13 in reference 2). Anti-S. aureus Igs were studied in 10 of the patients. Five of the patients were studied 1-3 wk after the onset of an S. aureus infection (two, subcutaneous abscesses; one, bronchitis; one, lung abscess; and one, pneumonia). Six of the HIE group were in relatively good health but had experienced a S. aureus infection in the previous 2 yr (one, pneumonia; one, subcutaneous abscess; one, osteomyelitis; and three, bronchitis). On one occasion, sera from three of these patients were pooled, aliquoted, frozen, and used as an "among assay" reference standard for the quantification of serum anti-S. aureus IgE. Separate serum samples from these three patients were included in the anti-S. aureus Patients with the Chediak-Higashi syndrome (CHS). Three CHS patients (aged 17-33; mean±SEM = 27.0±5.0) were studied (9) . One had a history of recurrent superficial pustules caused by S. aureus, one had an acute perirectal abscess secondary to Escherichia coli at the time the serum was obtained, and one had been relatively free of significant infections for many years.
Patients with eczema and recurrent superficial S. aureus infections. The five patients (aged 6-39; mean±SEM = 22.2±6.3) in this category were referred to the NIH for consideration of the diagnosis of HIE because of markedly elevated IgE and a long history of recurrent but usually superficial S. aureus infections complicating chronic eczematoid dermatitis. One patient had an active S. aureus infection at the time of study, and four were clinically well except for diffuse eczema. All had experienced significant infections within the preceding year.
Sera
The serum samples were obtained before breakfast, allowed to clot at room temperature for Tested against IgD, the anti-IgE had a 10'-fold specificity whereas the anti-IgM had a 103-fold specificity, and the anti-IgA had a 102-fold specificity. The anti-IgG had a 25-fold specificity when tested against IgD, a 102-fold specificity against IgM, a 103-fold specificity against IgA, and a 104-fold specificity against IgE. Thus, cross-reactivity of our conjugates with contaminating Ig's was negligible, and, in fact, the observed cross-reactivity may be secondary to Examples of standard curves are shown in Fig. 1 . As seen, the anti-S. aureus IgG standard curve (Fig. I A) is obtained with dilutions in the reference serum pool of from 1:10,000 to 1:160,000. In the anti-S. aureus IgE assay (Fig. I B) , the HIE reference pool was used at dilutions ranging from 1:10 to 1:80. S. aureus Ig determinations are expressed as arbitrary units (AU) per milliliter, in which I AU/ml of anti-S. aureus IgG represents the amount present in a 1:10,000 dilution of the normal serum pool, and I AU/ml of anti-S. aureus IgE the amount present in a 1:10 dilution of the HIE pool.
Assay ofserum anti-S. aureus IgA and IgM, and of salivary anti-S. aureus IgA (indirect method) The samples were assayed as above with the following changes: 100 Md of S. aureus suspension (A650 = 0.100; -2 X 108/ml), which yields saturating values in these assays, or of buffer A was placed into polypropylene tubes (12 X 75 mm), and 200 ul of serum or saliva diluted in buffer B was added. After incubation at room temperature with shaking for 4 h, 3 ml of buffer B was added, and the tubes were centrifuged at 7,000 g for 20 min at 40C. The uppermost 2.9 ml were aspirated, and the pellets were transferred to millititer plates with three washes of 0.5 ml of buffer B. Samples were then handled as in the direct method except that the salivary anti-S. aureus IgA samples were read in the spectrophotometer with a 1.99 expansion factor. (Conjugates were diluted 1:2,000 for both HRP-anti-IgA and HRP-anti-IgM.)
Examples of these standard curves are shown in Fig. 1 . As can be 
Results

Total Igs
Values of serum IgE and IgD in HIE and eczema patients were determined. In agreement with previously published data (1, 2, 6 ), as compared with the normal subjects, the HIE patients had higher levels of serum IgE (geometric mean X/*.+ SEM = 4,496 X/. 1.39 IU/ml, range 1,163 to 24,190 IU/ml vs. geometric mean X/. SEM = 55.7 X/. 1.21 IU/ml, range 25 to 133 IU/ml; P < 0.01) and higher levels of serum IgD (geometric mean X/. SEM = 54.6 X/. 1.49 IU/ml, range 12 to 384 IU/ml vs. geometric mean X/. SEM = 9.1 X/. 1.43 IU/ml, range 0.3 to 75 IU/ml; P < 0.01). Five patients with eczema and recurrent superficial S. aureus infections also had elevated IgE levels (geometric mean X/. SEM = 2,704 X/. 1.95 IU/ml, range 266 to 7,897 IU/ml, P < 0.001). Three patients had levels that were higher than the geometric mean for the HIE patients.
During the past 2 yr, 34 serum samples from 11 HIE patients, 7 samples from 5 eczema patients, and 23 samples from 15 CGD patients have been assayed for IgG, IgA, and IgM. Ig levels for single serum samples from 28 normal volunteers were also obtained. As compared with the normal population (Fig. 2) , the HIE patients had higher levels of IgG (geometric mean, 1,593 vs. 1,280 mg/dl; P < 0.01), normal levels of IgA (geometric mean, 161 vs. 217 mg/dl; not statistically significant), and higher levels of IgM (geometric mean, 200 vs. 135 mg/dl, P < 0.05). Note that 3 of the 11 HIE patients had relatively low levels of total IgA.
The CGD patients as a group were found to have normal levels of total serum IgG and essentially normal levels of total serum IgA but unexpectedly low levels of serum IgM (P < 0.05) (Fig. 2) . There was a wide difference in total IgM values for the HIE patients (geometric mean, 200 mg/dl) as compared with the CGD patients (geometric mean, 95 mg/dl; P < 0.001).
Anti-S. aureus Igs Anti-S. aureus IgE and IgD. Anti-S. aureus IgE values (Fig.   3 ) were elevated in 9 of 10 patients with HIE (3.0 AU/ml), confirming earlier reports (3, 4) . The one patient with undetectable anti-S. aureus IgE was unusual in that his primary infectious process was cryptococcal esophagitis (26) , although he had had occasional S. aureus skin abscesses. As expected, HIE patients with more IgE have more anti-S. aureus IgE, with a significant correlation between total IgE and anti-S. aureus IgE (r = 0.84, P = 0.002). In contrast with published reports (5) and in agreement with a recent observation (27) , our assay indicated that patients with eczema and recurrent superficial S. aureus infections did not have detectable anti-S. aureus IgE (lower limits of detectability, 0.1 AU/ml). Normal serum -plus myeloma IgE (1,500 ng/ml) did not have detectable anti-S. aureus IgE. Anti-S. aureus IgD was found in low titer in five HIE patients and in four normal control subjects without evidence of marked differences (data not shown).
Anti-S. aureus IgG. Anti-S. aureus IgG levels (Fig. 4) 103 AU/ml; P < 0.02) subjects (circles). The GCD patients with recent S. aureus infection had higher anti-S. aureus IgG than did CGD patients without a history of recent S. aureus infections (triangles) (geometric mean = 10.7 X 103 AU/ml, P < 0.01).
Anti-S. aureus IgA (Fig. 5) . The HIE patients' geometric mean levels of serum anti-S. aureus IgA (1.2 X 102 AU/ml) were significantly lower than those of the normal control subjects (7.5 X 102 AU/ml, P < 0.001), all patients with CGD (12.4 X 102 AU/ml, P < 0.01), CGD patients with recent S. aureus infections (21.6 X 102 AU/ml, P < 0.001), CGD patients without documented recent S. aureus infection (8.3 X 102 AU/ml, P < 0.05), patients with CHS (14.1 X 102 AU/ ml, P < 0.02), and patients with eczema and recurrent superficial S. aureus infections (25.4 X 102 AU/ml, P < 0.001). There is also a positive correlation between total serum IgA and serum anti-S. aureus IgA (r = 0.8 1, P = 0.004). However, a significant correlation could not be demonstrated between total IgA and total IgE, or between anti-S. aureus IgA and anti-S. aureus IgE, or between salivary IgA (total or anti-S. aureus) and serum IgE (total or anti-S. aureus).
The CGD patients with recently documented S. aureus infections and the patients with eczema and recurrent superficial S. aureus infections had significantly higher anti-S. aureus IgA than did the normal population, suggesting that the lack of anti-S. aureus IgA in HIE is peculiar to this syndrome and is not an effect of frequent S. aureus infection. The low levels of anti-S. aureus IgA in HIE (1.2 X 102 AU/ml) are even more marked when compared with the larger amounts in the recently infected control groups (eczema patients, 25 .4 X 102 AU/ml; recently infected CGD patients, 21 .6 X 102 AU/ml). (P < 0.01), CGDf (P < 0.05), CGD* (P < 0.01), eczema (ECZ) (P < 0.001), and CHS (P < 0.02) patients. CGD* vs. NL (P < 0.02) patients. ECZ vs. NL (P < 0.01) patients. Other statistical comparisons were not significant.
Anti-S. aureus IgM. In patients with HIF, the levels of anti-S. aureus IgM (geometric mean = 29.6 X 102 AU/ml), (Fig. 6) were significantly higher than those in normal control subjects (10.6 X 102 AU/ml, P < 0.001), all CGD patients (9.4 X 102 AU/ml, P < 0.01), and patients with CHS (12.0 X 102 AU/ml, P < 0.01), Even those HIE patients without acute infections (open circles) tended to have higher than normal values of anti-S. aureus IgM.
Further investigation ofIgA in HIE Serum IgA directed against E. coli J5 LPS and the polyvalent pneumococcal vaccine polysaccharides. To evaluate the specificity of anti-S. aureus IgA deficiency in HIE, we chose to measure the levels of serum IgA directed against both the E. coli J5 LPS (22) and the antigens of the polyvalent pneumococcal vaccine in eight HIE patients and seven normal people, none of whom had been vaccinated with the pneumococcal vaccine (Fig. 7) . Most of the HIE patients had normal or above normal serum anti-E. coli J5 LPS IgA. Similar data were obtained for anti-pneumococcal IgA. It is interesting that one patient had an undetectably low level of anti-E. coli J5 LPS IgA. She also had the lowest value of anti-pneumococcal polysaccharide IgA and among the lowest values for anti-S. aureus IgA in both serum and saliva (see below) and the lowest value of total IgA (54 mg/dl; normal range, 65-415 ng/ dl). Thus, she may have a more generalized inability to mount 30 S. C. Dreskin, P. K. Goldsmith, and J. I. Gallin o, other patients with history of recent (within 2 yr) infections; A, normal control subjects (NL) and patients with no history of recent S. aureus infections. The geometric mean and relative SE are shown for each group. To simplify the figure, only one SE is shown for the CGD patients. However, for statistical comparisons, these patients can be considered as a whole (CGD) or as two groups, those with recent S. aureus infections (CGD)* and those without recently documented S. aureus infections (CGD).t HIE vs. NL (P < 0.001), CGD (P < 0.01), CGDf (P < 0.01), CGD* (P < 0.01), and CHS (P < 0.01). Other comparisons were not significant. Eczema (ECZ).
an antigen-specific IgA response. Nonetheless, in HIE patients as a group, the serum IgA against these common bacterial antigens was normal. This was in marked contrast to the deficiency of anti-S. aureus IgA shown in Fig. 5 and, in conjunction with the evidence of normal total serum IgA ( Fig 2), suggested that this abnormality of circulating anti-S. aureus IgA was probably restricted to idiotypes recognizing a specific antigen or set of antigens.
Salivary anti-S. aureus IgA
The finding that patients with HIE have a deficit of anti-S. aureus serum IgA led to the evaluation of salivary IgA and salivary anti-S. aureus IgA in these patients. As Fig. 8 shows, the patients with HIE have significantly decreased levels of salivary IgA per milligram of protein (Fig. 8 A) and decreased salivary anti-S. aureus IgA per milligram of protein (Fig. 8 B) as compared with the normal controls (P < 0.01 and P < 0.05, respectively Correlation with infection 9 of the 10 HIE patients studied had detectable anti-S. aureus IgE. In these patients, infections occurring at sites (see Methods) where IgA may be an important host defense accounted for 75% (42 of 56) of all infections. 52% of these infections were due to S. aureus, 17% to Haemophilus influenzae, and 17% to C. albicans. There was an inverse correlation between serum anti-S. aureus IgA and the number of infections (Fig. 9 A; r = -0.647, P = 0.034). A similar negative correlation was seen between serum anti-S. aureus IgE and the number of infections (Fig. 9 B ; r = -0.731, P = 0.016). Negative correlations with the number of infections were also noted for total serum IgE (Fig. 9 C; r = -0.714; P = 0.020) and for total serum IgD (Fig. 9 D ; r =-0.597, P = 0.049). Other Ig's including serum anti-S. aureus IgG, serum anti-S. aureus IgM, salivary IgA, and anti-S. aureus IgA were not significantly correlated with the number of infections. If all infections (regardless of organism or site) were included, the negative correlation with anti-S. aureus IgE retained significance (r = -0.593, P = 0.050) as did the correlation with total serum IgD (r = -0.729, P = 0.016), but the other negative correlations lost their significance. When the 14 nonmucosal infections (80% of which were S. aureus abscesses) were considered separately, no significant correlations were found.
Discussion
The immunologic defect in HIE is not understood, but recent evidence suggests that there is an abnormality in the production of Ig after stimulation in vitro with pokeweed mitogen (13) and exposure of patients to exogenous antigens in vivo (1, 28 not shown) of anti-C. albicans serum IgA in HIE, we found a marked deficit in two of six patients tested and a moderate deficit in one other. Thus, there is a deficit of serum IgA against C. albicans, but it does not appear to be as prominent as the deficit of anti-S. aureus serum IgA. The role of serum IgA is unknown, although there is evidence that it is important in the body's defense against Neisseria meningitis (31) . Secretory IgA on the other hand has a well-defined role in interfering with bacterial adherence (32, 33) and may be important in the phagocytosis of bacteria by oral neutrophils (34) . The possibility that deficiencies of organism-specific serum and secretory IgA contribute to the recurrent mucosal infections in HIE is intriguing and merits additional investigation.
The negative correlation between serum levels of total IgE, anti-S. aureus IgE, and total IgD with the number of infections (Fig. 9, A-D) suggests that these substances are not responsible for recurrent infections in HIE and may be protective. If IgE were detrimental, one would expect a positive correlation between the incidence of infection and the IgE levels. Alternatively, IgE and anti-S. aureus IgE may play a dual role such that the presence of large amounts of IgE is detrimental (35) but that even larger amounts of IgE are protective. Evidence for a protective role for IgE has been published (36) . Rat IgE can mediate rat eosinophil-dependent cytotoxicity against Shistosoma mansoni shistosomula (37) and has been shown to interact with monocytes from atopic patients and to mediate monocyte cytotoxic function against IgE-coated target cells (38) .
The demonstration of a deficiency of anti-S. aureus IgA (in serum and saliva) in conjunction with elevated serum anti-S. aureus IgE, elevated serum anti-S. aureus IgM, and the lack of an expected excess of serum anti-S. aureus IgG describes a unique abnormality of the humoral immune system in HIE. These findings offer new insight into the basis of increased susceptibility to infection in the HIE syndrome and open new avenues for the investigation of isotype-specific responsiveness to common pathogens in man.
